Quantifying the Economic Impact of Delayed Multiple-Inhaler Triple Therapy Initiation in Patients with COPD: A Retrospective Cohort Study of Linked Electronic Medical Record and Hospital Administrative Data in England.
Leah B SansburyRobert P WoodGlenn A AnleyYein NamAfisi S IsmailaPublished in: International journal of chronic obstructive pulmonary disease (2021)
Delayed initiation of multiple-inhaler triple therapy was associated with higher all-cause and COPD-related costs, suggesting that earlier initiation of triple therapy in COPD patients may help reduce the economic burden on the healthcare system.
Keyphrases
- chronic obstructive pulmonary disease
- lung function
- end stage renal disease
- healthcare
- chronic kidney disease
- ejection fraction
- emergency department
- stem cells
- peritoneal dialysis
- prognostic factors
- cystic fibrosis
- mesenchymal stem cells
- artificial intelligence
- bone marrow
- patient reported
- smoking cessation
- replacement therapy